Phase 3 DR10624 vs Placebo in Subjects With Severe Hypertriglyceridemia on Stable Lipid Therapy
18h agoen
From the article
Conditions : Severe Hypertriglyceridemia (sHTG); Hypertriglyceridemia Interventions : Biological: DR10624 Injection; Other: Matching Placebo for DR10624 Sponsors : Zhejiang Doer Biologics Co., Ltd. Not yet recruiting
Continue reading on clinicaltrials.gov
Comments
Sign in to join the conversation.
No comments yet. Be the first.